Cited by 152Drug Transport and Resistance MechanismsBarrier Structure and Function StudiesPharmacogenetics and Drug Metabolism

The DOI matches its Crossref record; 375 of the 379 references it cites were found in a registry or an index.

Dysfunction of ABC transporters at the blood-brain barrier: Role in neurological disorders

Gil-Martins, Eva, Barbosa, Daniel José, Silva, Vera, Remião, Fernando, Silva, Renata·2020·Pharmacology & Therapeutics

DOI 10.1016/j.pharmthera.2020.107554

Open this paper in CoChat — free account

Abstract

ABC (ATP-binding cassette) transporters represent one of the largest and most diverse superfamily of proteins in living species, playing an important role in many biological processes such as cell homeostasis, cell signaling, drug metabolism and nutrient uptake. Moreover, using the energy generated from ATP hydrolysis, they mediate the efflux of endogenous and exogenous substrates from inside the cells, thereby reducing their intracellular accumulation. At present, 48 ABC transporters have been identified in humans, which were classified into 7 different subfamilies (A to G) according to their phylogenetic analysis. Nevertheless, the most studied members with importance in drug therapeutic efficacy and toxicity include P-glycoprotein (P-gp), a member of the ABCB subfamily, the multidrug-associated proteins (MPRs), members of the ABCC subfamily, and breast cancer resistance protein (BCRP), a member of the ABCG subfamily. They exhibit ubiquitous expression throughout the human body, with a special relevance in barrier tissues like the blood-brain barrier (BBB). At this level, they play a physiological function in tissue protection by reducing or limiting the brain accumulation of neurotoxins. Furthermore, dysfunction of ABC transporters, at expression and/or activity level, has been associated with many neurological diseases, including epilepsy, multiple sclerosis, Alzheimer's disease, and amyotrophic lateral sclerosis. Additionally, these transporters are strikingly associated with the pharmacoresistance to central nervous system (CNS) acting drugs, because they contribute to the decrease in drug bioavailability. This article reviews the signaling pathways that regulate the expression and activity of P-gp, BCRP and MRPs subfamilies of transporters, with particular attention at the BBB level, and their mis-regulation in neurological disorders.

Integrity signals

Registry

Crossref · 10.1016/j.pharmthera.2020.107554

Cites

375 of 375 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Items 201–375 of 375

Targeting xenobiotic receptors PXR and CAR in human diseases
Banerjee, M., Robbins, D. F., & Chen, T. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2014.11.011 · Cited by 114
Opioids and the Blood-Brain Barrier: A Dynamic Interaction with Consequences on Drug Disposition in Brain
Chaves, C., Remião, F., Cisternino, S., & Declèves, X. (2017) · Current Neuropharmacology · doi:10.2174/1570159x15666170504095823 · Cited by 114
Self-citation
MDR1 P-glycoprotein is expressed by endothelial cells of newly formed capillaries in human gliomas but is not expressed in the neovasculature of other primary tumors.
Tóth, K., Vaughan, M. M., Peress, N. S., Slocum, H. K., & Rustum, Y. M. (1996) · PubMed Central · Cited by 114
Aryl hydrocarbon receptor‐mediated up‐regulation of ATP‐driven xenobiotic efflux transporters at the blood‐brain barrier
Wang, X., Hawkins, B. T., & Miller, D. S. (2010) · The FASEB Journal · doi:10.1096/fj.10-169227 · Cited by 113
The biological and clinical role of drug transporters at the intestinal barrier
Oostendorp, R. L., Beijnen, J. H., & Schellens, J. H. M. (2008) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2008.09.004 · Cited by 113
The intrinsic severity hypothesis of pharmacoresistance to antiepileptic drugs
Rogawski, M. A. (2013) · Epilepsia · doi:10.1111/epi.12182 · Cited by 110
P-glycoprotein and MRP1 expression and reduced ritonavir and saquinavir accumulation in HIV-infected individuals
Meaden, E. R. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkf161 · Cited by 110
Temozolomide competes for P-glycoprotein and contributes to chemoresistance in glioblastoma cells
Munoz, J. L., Walker, N. D., Scotto, K. W., & Rameshwar, P. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.07.013 · Cited by 110
Up‐regulation of P‐glycoprotein by HIV protease inhibitors in a human brain microvessel endothelial cell line
Zastre, J. A., Chan, G. N. Y., Ronaldson, P. T., Ramaswamy, M., Couraud, P. O., Romero, I. A., Weksler, B. B., Bendayan, M., & Bendayan, R. (2008) · Journal of Neuroscience Research · doi:10.1002/jnr.21898 · Cited by 108
Rapid, Reversible Modulation of Blood–Brain BarrierP-Glycoprotein Transport Activity by Vascular Endothelial Growth Factor
Hawkins, B. T., Sykes, D. B., & Miller, D. S. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.5103-09.2010 · Cited by 107
A Role for P-Glycoprotein in Clearance of Alzheimer Amyloid ? -Peptide from the Brain
Wang, W., M. Bodles-Brakhop, A., & W. Barger, S. (2016) · Current Alzheimer Research · doi:10.2174/1567205013666160314151012 · Cited by 107
Association between ABCB1 C3435T polymorphism and drug-resistant epilepsy in Han Chinese
Kwan, P., Baum, L., Wong, V. C. N., Ng, P. W., Lui, C. H. T., Sin, N. C., Hui, A. C.-F., Yu, E., & Wong, K. S. (2007) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2007.04.013 · Cited by 106
Regulation of major efflux transporters under inflammatory conditions at the blood‐brain barrierin vitro
von Wedel-Parlow, M., Wölte, P., & Galla, H. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06305.x · Cited by 106
The effect of P-glycoprotein on paclitaxel brain and brain tumor distribution in mice.
Gallo, J. M., Li, S., Guo, P., Reed, K., & Ma, J. (2003) · PubMed · Cited by 105
Neurovascular Pathways and Alzheimer Amyloid β-peptide
Zlokovic, B. V., Deane, R., Sallstrom, J., Chow, N., & Miano, J. M. (2006) · Brain Pathology · doi:10.1111/j.1750-3639.2005.tb00103.x · Cited by 104
Opioid Analgesics and P-Glycoprotein Efflux Transporters: A Potential Systems-Level Contribution to Analgesic Tolerance
Mercer, S. L., & Coop, A. (2011) · Current Topics in Medicinal Chemistry · doi:10.2174/156802611795371288 · Cited by 103
Obstacles to Brain Tumor Therapy: Key ABC Transporters
Wijaya, J., Fukuda, Y., & Schuetz, J. D. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18122544 · Cited by 101
Blood-brain barrier is impaired in the hippocampus of young adult spontaneously hypertensive rats
Ueno, M., Sakamoto, H., Tomimoto, H., Akiguchi, I., Onodera, M., Huang, C., & Kanenishi, K. (2004) · Acta Neuropathologica · doi:10.1007/s00401-004-0845-z · Cited by 100
HIV‐1 viral envelope glycoprotein gp120 produces oxidative stress and regulates the functional expression of multidrug resistance protein‐1 (Mrp1) in glial cells
Ronaldson, P. T., & Bendayan, R. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05479.x · Cited by 100
Targeting Prostaglandin E2 EP1 Receptors Prevents Seizure-Associated P-glycoprotein Up-Regulation
Pekcec, A., Unkrüer, B., Schlichtiger, J., Soerensen, J., Hartz, A. M. S., Bauer, B., van Vliet, E. A., Gorter, J. A., & Potschka, H. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.152520 · Cited by 97
Both P-gp and MRP2 mediate transport of Lopinavir, a protease inhibitor
Agarwal, S., Pal, D., & Mitra, A. K. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.02.036 · Cited by 95
P-glycoprotein-mediated efflux of antiepileptic drugs: preliminary studies in mdr1a knockout mice
Sills, G. J., Kwan, P., Butler, E., de Lange, E. C. M., van den Berg, D., & Brodie, M. J. (2002) · Epilepsy & Behavior · doi:10.1016/s1525-5050(02)00511-5 · Cited by 95
Inhibiting drug efflux transporters improves efficacy of ALS therapeutics
Jablonski, M., Markandaiah, S. S., Jacob, D. A., Meng, N. J., Li, K., Gennaro, V. J., Lepore, A. C., Trotti, D., & Pasinelli, P. (2014) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.141 · Cited by 94
HIV-TAT Protein Upregulates Expression of Multidrug Resistance Protein 1 in the Blood–Brain Barrier
Hayashi, K., Pu, H., Andras, I. E., Eum, S. Y., Yamauchi, A., Hennig, B., & Toborek, M. J. (2006) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600254 · Cited by 94
Expression of multidrug-resistance P-glycoprotein (MDR1) in human brain tumors
Demeule, M., Shédid, D., Beaulieu, �., Maestro, R. F. D., Moghrabi, A., Ghosn, P., Moumdjian, R. A., Berthelet, F., & B�liveau, R. (2001) · International Journal of Cancer · doi:10.1002/ijc.1306 · Cited by 93
Selective increase of two ABC drug efflux transporters at the blood–spinal cord barrier suggests induced pharmacoresistance in ALS
Jablonski, M., Jacob, D. A., Campos, C. R., Miller, D. S., Maragakis, N. J., Pasinelli, P., & Trotti, D. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.03.040 · Cited by 91
Regulation of Multidrug Resistance by Pro-Inflammatory Cytokines
Ho, E. A., & Piquette‐Miller, M. (2006) · Current Cancer Drug Targets · doi:10.2174/156800906777441753 · Cited by 90
Adenosine triphosphate-binding cassette transporters mediate chemokine (C-C motif) ligand 2 secretion from reactive astrocytes: relevance to multiple sclerosis pathogenesis
Kooij, G., Mizee, M. R., van Horssen, J., Reijerkerk, A., Witte, M. E., Drexhage, J. A. R., van der Pol, S. M. A., van het Hof, B., Scheffer, G., Scheper, R., et al. (2011) · Brain · doi:10.1093/brain/awq330 · Cited by 90
Influence of CYP 2D6, CYP 3A4, CYP 3A5 and ABCB 1 Polymorphisms on Pharmacokinetics and Safety of Aripiprazole in Healthy Volunteers
Belmonte, C., Ochoa, D., Román, M. C., Saiz‐Rodríguez, M., Wojnicz, A., Gómez‐Sánchez, C. I., Martín‐Vílchez, S., & Abad‐Santos, F. (2018) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.12960 · Cited by 89
Reduced Alzheimer’s Disease Pathology by St. John’s Wort Treatment is Independent of Hyperforin and Facilitated by ABCC1 and Microglia Activation in Mice
Hofrichter, J., Krohn, M., Schumacher, T., Lange, C., Feistel, B., Walbroel, B., Heinze, H., Crockett, S. L., Sharbel, T. F., & Pahnke, J. (2013) · Current Alzheimer Research · doi:10.2174/15672050113106660171 · Cited by 88
Prion diseases
Ironside, J. W., Ritchie, D. L., & Head, M. W. (2017) · Handbook of clinical neurology · doi:10.1016/b978-0-12-802395-2.00028-6 · Cited by 88
ABC transporters in drug-resistant epilepsy: mechanisms of upregulation and therapeutic approaches
Leandro, K., Bicker, J., Alves, G., Falcão, A. C., & Fortuna, A. C. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.04.031 · Cited by 87
Cerebral expression of drug transporters in epilepsy
Aronica, E., Sisodiya, S. M., & Gorter, J. A. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.11.008 · Cited by 86
Molecular and functional MDR1‐Pgp and MRPs expression in human glioblastoma multiforme cell lines
Declèves, X., Fajac, A., Lehmann‐Che, J., Tardy, M., Mercier, C., Hurbain, I., Laplanche, J., Bernaudin, J., & Scherrmann, J. (2002) · International Journal of Cancer · doi:10.1002/ijc.10135 · Cited by 86
P-glycoprotein expression in brain tumors
Henson, J., Cordon‐Cardo, C., & Posner, J. B. (1992) · Journal of Neuro-Oncology · doi:10.1007/bf00170943 · Cited by 85
Alzheimer’s and ABC transporters — new opportunities for diagnostics and treatment
Pahnke, J., Langer, O., & Krohn, M. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.04.001 · Cited by 84
Minocycline and riluzole brain disposition: interactions with p‐glycoprotein at the blood–brain barrier
Milane, A., Fernandez, C., Vautier, S., Bensimon, G., Meininger, V., & Farinotti, R. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04772.x · Cited by 83
Beta‐Amyloid Downregulates MDR1‐P‐Glycoprotein (Abcb1) Expression at the Blood‐Brain Barrier in Mice
Brenn, A., Grube, M., Peters, M., Fischer, A., Jedlitschky, G., Kroemer, H. K., Warzok, R., & Vogelgesang, S. (2011) · International Journal of Alzheimer s Disease · doi:10.4061/2011/690121 · Cited by 80
Pro-Inflammatory Cytokine Regulation of P-glycoprotein in the Developing Blood-Brain Barrier
Iqbal, M., Ho, H. L., Sophie Petropoulos, A., Moisiadis, V. G., Gibb, W., & Matthews, S. G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043022 · Cited by 79
Up‐regulation of P‐glycoprotein expression by glutathione depletion‐induced oxidative stress in rat brain microvessel endothelial cells
Hong, H., Lu, Y., Zhao-ning, J., & Liu, G. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03993.x · Cited by 79
Lack of association between C3435T nucleotide MDR1 genetic polymorphism and multidrug-resistant epilepsy
Kim, D. W., Kim, M., Lee, S. K., 강라미, & Lee, S.-Y. (2006) · Seizure · doi:10.1016/j.seizure.2006.02.015 · Cited by 79
HIV‐Tat protein induces P‐glycoprotein expression in brain microvascular endothelial cells
Hayashi, K., Pu, H., Tian, J., Andras, I. E., Lee, Y. W., Hennig, B., & Toborek, M. J. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03114.x · Cited by 78
Lack of association between ABCB1, ABCG2, and ABCC2 genetic polymorphisms and multidrug resistance in partial epilepsy
Kim, D. W., Lee, S. K., Chu, K., Jang, I., Yu, K., Cho, J., & Kim, S.-J. (2009) · Epilepsy Research · doi:10.1016/j.eplepsyres.2008.12.001 · Cited by 77
Glutamate is critically involved in seizure-induced overexpression of P-glycoprotein in the brain
Bankstahl, J. P., Hoffmann, K., Bethmann, K., & Löscher, W. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.02.008 · Cited by 77
Locally increased P-glycoprotein function in major depression: a PET study with [11C]verapamil as a probe for P-glycoprotein function in the blood–brain barrier
de Klerk, O. L., Willemsen, A. T. M., Roosink, M., Bartels, A. L., Hendrikse, N. H., Bosker, F. J., & den Boer, J. A. (2009) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145709009894 · Cited by 75
Brain accumulation of the EML4-ALK inhibitor ceritinib is restricted by P-glycoprotein (P-GP/ABCB1) and breast cancer resistance protein (BCRP/ABCG2)
Kort, A., Sparidans, R. W., Wagenaar, E., Beijnen, J. H., & Schinkel, A. H. (2015) · Pharmacological Research · doi:10.1016/j.phrs.2015.09.003 · Cited by 75
P-gp Protein Expression and Transport Activity in Rodent Seizure Models and Human Epilepsy
Hartz, A. M. S., Pekcec, A., Soldner, E. L. B., Zhong, Y., Schlichtiger, J., & Bauer, B. (2017) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6b00770 · Cited by 75
Regional increase in P-glycoprotein function in the blood-brain barrier of patients with chronic schizophrenia:
de Klerk, O. L., Willemsen, A. T. M., Bosker, F. J., Bartels, A. L., Hendrikse, N. H., den Boer, J. A., & Dierckx, R. A. (2010) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2010.05.002 · Cited by 74
T lymphocytes impair P-glycoprotein function during neuroinflammation
Kooij, G., van Horssen, J., de Lange, E. C. M., Reijerkerk, A., van der Pol, S. M. A., Hof, B. V. H., Drexhage, J., Vennegoor, A., Killestein, J., Scheffer, G. L., et al. (2009) · Journal of Autoimmunity · doi:10.1016/j.jaut.2009.10.006 · Cited by 70
Regulation of ABC Transporters at the Blood-Brain Barrier: New Targets for CNS Therapy
Hartz, A. M. S., & Bauer, B. (2010) · Molecular Interventions · doi:10.1124/mi.10.5.6 · Cited by 70
Astrocytes drive upregulation of the multidrug resistance transporter ABCB1 (P‐Glycoprotein) in endothelial cells of the blood–brain barrier in mutant superoxide dismutase 1‐linked amyotrophic lateral sclerosis
Qosa, H., Lichter, J., Sarlo, M., Markandaiah, S. S., McAvoy, K., Richard, J., Jablonski, M., Maragakis, N. J., Pasinelli, P., & Trotti, D. (2016) · Glia · doi:10.1002/glia.23003 · Cited by 70
Up-regulation of P-glycoprotein reduces intracellular accumulation of beta amyloid: investigation of P-glycoprotein as a novel therapeutic target for Alzheimer's disease
Abuznait, A. H., Cain, C. M., Ingram, D., Burk, D. H., & Kaddoumi, A. (2011) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.2011.01309.x · Cited by 69
Drug transport across the placenta, role of the ABC drug efflux transporters
Behravan, J., & Piquette‐Miller, M. (2007) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.3.6.819 · Cited by 69
The multidrug-resistance gene MDR1 is expressed in human glial tumors
Becker, I., Becker, K., Meyermann, R., & H�llt, V. (1991) · Acta Neuropathologica · doi:10.1007/bf00293387 · Cited by 68
Alzheimer’s Disease, Cholesterol, and Statins: The Junctions of Important Metabolic Pathways
Silva, T., Teixeira, J., Remião, F., & Borges, F. (2012) · Angewandte Chemie International Edition · doi:10.1002/anie.201204964 · Cited by 68
Self-citation
Differential regulation of transport proteins in the periinfarct region following reversible middle cerebral artery occlusion in rats
Dazert, P., Suofu, Y., Grube, M., Popa‐Wagner, A., Kroemer, H. K., Jedlitschky, G., & Kessler, C. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.07.056 · Cited by 66
PEGylated PLGA Nanoparticles As a Smart Carrier to Increase the Cellular Uptake of a Coumarin-Based Monoamine Oxidase B Inhibitor
Fernandes, C., Martins, C., Fonseca, A., Nunes, R., Matos, M. J., Silva, R. V. D. S., Garrido, J., Sarmento, B. F. C. C., Remião, F., Otero-Espinar, F. J., et al. (2018) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.8b17224 · Cited by 66
Self-citation
Drug-resistant epilepsy: From multiple hypotheses to an integral explanation using preclinical resources
Pérez‐Pérez, D., Frías‐Soria, C. L., & Rocha, L. (2019) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2019.07.031 · Cited by 66
An ALS mouse model with a permeable blood–brain barrier benefits from systemic cyclosporine A treatment
Kirkinezos, I. G., Hernandez, D., Bradley, W. G., & Moraes, C. T. (2004) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02181.x · Cited by 66
ABCC1: a gateway for pharmacological compounds to the ischaemic brain
Kılıç, E., Spudich, A., Kılıç, Ü., Rentsch, K., Vig, R., Matter, C. M., Wunderli‐Allenspach, H., Fritschy, J., Bassetti, C. L., & Hermann, D. M. (2008) · Brain · doi:10.1093/brain/awn222 · Cited by 65
Ceramide Kinase Regulates the Production of Tumor Necrosis Factor α (TNFα) via Inhibition of TNFα-converting Enzyme
Lamour, N. F., Wijesinghe, D. S., Mietla, J. A., Ward, K. E., Stahelin, R. V., & Chalfant, C. E. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.310169 · Cited by 65
Signalling pathways influencing basal and H2O2‐induced P‐glycoprotein expression in endothelial cells derived from the blood–brain barrier
Nwaozuzu, O. M., Sellers, L. A., & Barrand, M. A. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02061.x · Cited by 64
MRP3, a new ATP-binding cassette protein localized to the canalicular domain of the hepatocyte
Ortiz, D. F., Li, S., Iyer, R., Zhang, X., Novikoff, P. M., & Arias, I. M. (1999) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1999.276.6.g1493 · Cited by 64
Beta amyloid effects on expression of multidrug efflux transporters in brain endothelial cells.
Kania, K., Wijesuriya, H. C., Hladky, S., & Barrand, M. (2011) · Brain Research · doi:10.1016/j.brainres.2011.08.044 · Cited by 63
Brain-Targeted Drug Delivery
Bodor, N. S., & Buchwald, P. (2003) · American Journal of Drug Delivery · doi:10.2165/00137696-200301010-00002 · Cited by 62
Neuronal mdr-1 gene expression after experimental focal hypoxia: A new obstacle for neuroprotection?
Lazarowski, A., Caltana, L. R., Merelli, A., Rubio, M. D., Ramos, A. J., & Brusco, A. (2007) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2007.03.004 · Cited by 61
Alteration in P-glycoprotein at the blood–brain barrier in the early period of MCAO in rats
Cen, J., Liu, L., Ming-shan, L., He, L., Wang, L., Liu, Y., Liu, M., & Ji, B. (2013) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.12033 · Cited by 60
Effect of 21-day exposure of phenobarbital, carbamazepine and phenytoin on P-glycoprotein expression and activity in the rat brain
Wen, T., Liu, Y.-C., Yang, H., Liu, H., Liu, X., Wang, G., & Xie, L. Y. (2008) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2008.02.016 · Cited by 59
P-glycoprotein expression and function are increased in an animal model of amyotrophic lateral sclerosis
Milane, A., Fernandez, C., Dupuis, L., Buyse, M., Loeffler, J., Farinotti, R., Meininger, V., & Bensimon, G. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2010.01.078 · Cited by 59
Verapamil and riluzole cocktail liposomes overcome pharmacoresistance by inhibiting P-glycoprotein in brain endothelial and astrocyte cells: A potent approach to treat amyotrophic lateral sclerosis
Yang, T., Ferrill, L., Gallant, L., McGillicuddy, S., Fernandes, T., Schields, N., & Bai, S. (2018) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2018.04.026 · Cited by 59
Targeted Metabolomics Identifies Glucuronides of Dietary Phytoestrogens as a Major Class of MRP3 Substrates In Vivo
van de Wetering, K., Feddema, W., Helms, J. B., Brouwers, J. F. H. M., & Borst, P. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.06.052 · Cited by 57
ABCB1 gene variants influence tolerance to selective serotonin reuptake inhibitors in a large sample of Dutch cases with major depressive disorder
de Klerk, O. L., Nolte, I. M., Bet, P. M., Bosker, F. J., Snieder, H., den Boer, J. A., Bruggeman, R., Hoogendijk, W. J. G., & Penninx, B. W. J. H. (2012) · The Pharmacogenomics Journal · doi:10.1038/tpj.2012.16 · Cited by 57
Tumors: Benign and Malignant
Sinha, T. (2018) · Cancer therapy & Oncology International Journal · doi:10.19080/ctoij.2018.10.555790 · Cited by 55
Polymorphisms in CYP1A2, CYP2C9 and ABCB1 affect agomelatine pharmacokinetics
Saiz‐Rodríguez, M., Ochoa, D., Belmonte, C., Román, M. C., de Lara, D. V., Zubiaur, P., Koller, D., Mejía-Abril, G. P., & Abad‐Santos, F. (2019) · Journal of Psychopharmacology · doi:10.1177/0269881119827959 · Cited by 54
Nordihydroguaiaretic acid increases glutamate uptake in vitro and in vivo: Therapeutic implications for amyotrophic lateral sclerosis
Boston-Howes, W., Williams, E. O., Bogush, A. I., Scolere, M., Pasinelli, P., & Trotti, D. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2008.06.010 · Cited by 53
P-glycoprotein regulates trafficking of CD8+ T cells to the brain parenchyma
Kooij, G., Kroon, J., Paul, D., Reijerkerk, A., Geerts, D., van der Pol, S. M. A., Hof, B. V. H., Drexhage, J., van Vliet, S. J., Hekking, L. H. P., et al. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1244-8 · Cited by 53
MRP3: a molecular target for human glioblastoma multiforme immunotherapy.
Kuan, C.-T., Wakiya, K., Herndon, J. E., Lipp, E., Pegram, C. N., Riggins, G. J., Rasheed, A., Szafranski, S. E., McLendon, R. E., Wikstrand, C. J., et al. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-468 · Cited by 53
Involvement of the Multidrug Resistance Protein 3 in Drug Sensitivity and Its Expression in Human Glioma
Haga, S., Hinoshita, E., Ikezaki, K., Fukui, M., Scheffer, G. L., Uchiumi, T., & Kuwano, M. (2001) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.2001.tb01084.x · Cited by 52
Association between the ABCG2 C421A polymorphism and Alzheimer's disease
Fehér, Á., Juhász, A., László, A., Pákáski, M., Kálmán, J., & Janka, Z. (2013) · Neuroscience Letters · doi:10.1016/j.neulet.2013.06.044 · Cited by 52
Excess glutamate secreted from astrocytes drives upregulation of P-glycoprotein in endothelial cells in amyotrophic lateral sclerosis
Mohamed, L. A., Markandaiah, S. S., Bonanno, S., Pasinelli, P., & Trotti, D. (2019) · Experimental Neurology · doi:10.1016/j.expneurol.2019.04.002 · Cited by 52
Antiepileptic drugs modulate P-glycoproteins in the brain: A mice study with 11C-desmethylloperamide
Moerman, L., Wyffels, L., Slaets, D., Raedt, R., Boon, P., & Vos, F. D. (2011) · Epilepsy Research · doi:10.1016/j.eplepsyres.2010.12.013 · Cited by 52
Development of luciferase tagged brain tumour models in mice for chemotherapy intervention studies
Kemper, E. M., Leenders, W. P. J., Küsters, B., Lyons, S. K., Buckle, T., Heerschap, A., Boogerd, W. J., Beijnen, J. H., & van Tellingen, O. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2006.07.013 · Cited by 51
Alzheimer Disease: Perspectives from Epidemiology and Genetics
Haines, J. L. (2018) · The Journal of Law Medicine & Ethics · doi:10.1177/1073110518804230 · Cited by 51
Genetic variability in ABCB1, occupational pesticide exposure, and Parkinson’s disease
Narayan, S., Sinsheimer, J. S., Paul, K. C., Liew, Z., Cockburn, M., Bronstein, J. M., & Ritz, B. R. (2015) · Environmental Research · doi:10.1016/j.envres.2015.08.022 · Cited by 50
Apolipoprotein E Controls ATP-Binding Cassette Transporters in the Ischemic Brain
ElAli, A., & Hermann, D. M. (2010) · Science Signaling · doi:10.1126/scisignal.2001213 · Cited by 49
Modulation of P‐glycoprotein function by sphingosine kinase‐1 in brain endothelial cells
Pilorget, A., Demeule, M., Barakat, S., Marvaldi, J. L., Luis, J., & Béliveau, R. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04295.x · Cited by 49
Mrp1 is Essential for Sphingolipid Signaling to P-Glycoprotein in Mouse Blood–Brain and Blood–Spinal Cord Barriers
Cartwright, T. A., Campos, C. R., Cannon, R. E., & Miller, D. S. (2012) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2012.174 · Cited by 48
Interactions between riluzole and ABCG2/BCRP transporter
Milane, A., Vautier, S., Chacun, H., Meininger, V., Bensimon, G., Farinotti, R., & Fernandez, C. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2008.12.061 · Cited by 48
Flavonoid compounds as reversing agents of the P-glycoprotein-mediated multidrug resistance: An in vitro evaluation with focus on antiepileptic drugs
Ferreira, A., Rodrigues, M., Fortuna, A. C., Falcão, A. C., & Alves, G. (2017) · Food Research International · doi:10.1016/j.foodres.2017.10.010 · Cited by 48
Gene Variants Associated With Ischemic Stroke
Luke, M. M., O’Meara, E. S., Rowland, C. M., Shiffman, D., Bare, L. A., Arellano, A. R., Longstreth, W. T., Jr., Lumley, T., Rice, K. M., Tracy, R. P., et al. (2008) · Stroke · doi:10.1161/strokeaha.108.521328 · Cited by 47
A reassessment of vascular endothelial growth factor in central nervous system pathology
Merrill, M. J., & Oldfield, E. H. (2005) · Journal of neurosurgery · doi:10.3171/jns.2005.103.5.0853 · Cited by 47
Expression of multi-drug resistance 1 mRNA in human and rodent tissues: reduced levels in Parkinson patients
Westerlund, M., Belin, A. C., Olson, L., & Galter, D. (2008) · Cell and Tissue Research · doi:10.1007/s00441-008-0686-5 · Cited by 45
Human MDR1 and MRP1 Recognize Berberine as Their Transport Substrate
Shitan, N., Tanaka, M., TERAI, K., Ueda, K., & Yazaki, K. (2007) · Bioscience Biotechnology and Biochemistry · doi:10.1271/bbb.60441 · Cited by 45
The Role of ATP-Binding Cassette Transporters in Neuro-Inflammation: Relevance for Bioactive Lipids
Kooij, G., van Horssen, J., Bandaru, V. V. R., Haughey, N. J., & de Vries, H. E. (2012) · Frontiers in Pharmacology · doi:10.3389/fphar.2012.00074 · Cited by 44
Oxidative stress-induced activation of Abl and Src kinases rapidly induces P-glycoprotein internalization via phosphorylation of caveolin-1 on tyrosine-14, decreasing cortisol efflux at the blood–brain barrier
Hoshi, Y., Uchida, Y., Tachikawa, M., Ohtsuki, S., Couraud, P., Suzuki, T., & Terasaki, T. (2019) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x18822801 · Cited by 44
A New Strategy for Glioblastoma Treatment: In Vitro and In Vivo Preclinical Characterization of Si306, a Pyrazolo[3,4-d]Pyrimidine Dual Src/P-Glycoprotein Inhibitor
Fallacara, A. L., Zamperini, C., Podolski-Renić, A., Dinić, J., Stanković, T., Stepanović, M., Mancini, A., Rango, E., Iovenitti, G., Molinari, A., et al. (2019) · Cancers · doi:10.3390/cancers11060848 · Cited by 44
Cerebrovascular P-glycoprotein expression is decreased in Creutzfeldt–Jakob disease
Vogelgesang, S., Glatzel, M., Walker, L. C., Kroemer, H. K., Aguzzi, A., & Warzok, R. (2006) · Acta Neuropathologica · doi:10.1007/s00401-006-0042-3 · Cited by 43
Induction of P‐glycoprotein and Bcrp at the rat blood–brain barrier following a subchronic morphine treatment is mediated through NMDA / COX ‐2 activation
Yousif, S., Chaves, C., Potin, S., Margaill, I., Scherrmann, J., & Declèves, X. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2012.07890.x · Cited by 43
Coexistence of CJD and Alzheimer's disease: An autopsy case showing typical clinical features of CJD
Tsuchiya, K., Yagishita, S., Ikeda, K., Sano, M., Taki, K., Hashimoto, K., WATABIKI, S., & Mizusawa, H. (2004) · Neuropathology · doi:10.1111/j.1440-1789.2003.00513.x · Cited by 43
P-glycoprotein induction in Caco-2 cells by newly synthetized thioxanthones prevents paraquat cytotoxicity
Silva, R., Palmeira, A., Carmo, H., Barbosa, D. J., Gameiro, M., Gomes, A. S., Paiva, A. M. O., Sousa, E., Pinto, M. M. M., Bastos, M. D. L., et al. (2014) · Archives of Toxicology · doi:10.1007/s00204-014-1333-4 · Cited by 43
Self-citation
Peptide Transport and Delivery into the Central Nervous System
(2003) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-8049-7 · Cited by 43
Induction and activation of P-glycoprotein by dihydroxylated xanthones protect against the cytotoxicity of the P-glycoprotein substrate paraquat
Silva, R., Sousa, E., Carmo, H., Palmeira, A., Barbosa, D. J., Gameiro, M., Pinto, M. M. M., Bastos, M. D. L., & Remião, F. (2014) · Archives of Toxicology · doi:10.1007/s00204-014-1193-y · Cited by 43
Self-citation
Brain and Plasma Riluzole Pharmacokinetics: Effect of Minocycline Combination
Milane, A., Tortolano, L., Fernandez, C., Bensimon, G., Meininger, V., & Farinotti, R. (2009) · Journal of Pharmacy & Pharmaceutical Sciences · doi:10.18433/j36c78 · Cited by 43
Spatiotemporal Changes in P-glycoprotein Levels in Brain and Peripheral Tissues Following Ischemic Stroke in Rats
DeMars, K. M., Yang, C., Hawkins, K. E., McCrea, A. O., Siwarski, D. M., & Candelario‐Jalil, E. (2017) · Journal of Experimental Neuroscience · doi:10.1177/1179069517701741 · Cited by 43
P-Glycoprotein Mediated Efflux Limits the Transport of the Novel Anti-Parkinson's Disease Candidate Drug FLZ across the Physiological and PD Pathological In Vitro BBB Models
Liu, Q., Hou, J., Chen, X., Liu, G.-T., Zhang, D., Sun, H., & Zhang, J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0102442 · Cited by 41
The coexistence of Alzheimer's disease and Creutzfeldt-Jakob disease in a patient with dementia of long duration
Muramoto, T., Kitamoto, T., Koga, H., & Tateishi, J. (1992) · Acta Neuropathologica · doi:10.1007/bf00227747 · Cited by 41
Activators of P‐glycoprotein: Structure–Activity Relationships and Investigation of their Mode of Action
Sterz, K., Möllmann, L., Jacobs, A., Baumert, D., & Wiese, M. (2009) · ChemMedChem · doi:10.1002/cmdc.200900283 · Cited by 41
In Vitro Assessment of the Effect of Antiepileptic Drugs on Expression and Function of ABC Transporters and Their Interactions with ABCC2
Grewal, G. K., Kukal, S., Kanojia, N., Madan, K., Saso, L., & Kukreti, R. (2017) · Molecules · doi:10.3390/molecules22101484 · Cited by 41
ABC Transporter Regulation by Signaling at the Blood–Brain Barrier
Miller, D. S. (2014) · Advances in pharmacology · doi:10.1016/bs.apha.2014.06.008 · Cited by 39
Functional Expression of Drug Transporters in Glial Cells
Ashraf, T., Kao, A. C.-C., & Bendayan, R. (2014) · Advances in pharmacology · doi:10.1016/bs.apha.2014.06.010 · Cited by 38
Convulsive Stress Mimics Brain Hypoxia and Promotes the P-Glycoprotein (P-gp) and Erythropoietin Receptor Overexpression. Recombinant Human Erythropoietin Effect on P-gp Activity
Merelli, A., Ramos, A. J., Lazarowski, A., & Auzmendi, J. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00750 · Cited by 38
Exposure to antiepileptic drugs does not alter the functionality of P-glycoprotein in brain capillary endothelial and kidney cell lines
Ambroziak, K., Kuteykin‐Teplyakov, K. B., Luna‐Tortós, C., Alfalah, M., Fedrowitz, M., & Löscher, W. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.11.051 · Cited by 37
P‐glycoprotein expression in immortalised rat brain endothelial cells: comparisons following exogenously applied hydrogen peroxide and after hypoxia–reoxygenation
Robertson, S. J., Kania, K., Hladky, S. B., & Barrand, M. A. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06306.x · Cited by 37
MicroRNA-146a-5p Downregulates the Expression of P-Glycoprotein in Rats with Lithium–Pilocarpine-Induced Status Epilepticus
Deng, X., Shao, Y., Xie, Y., Feng, Y., Wu, M., Wang, M., & Chen, Y. (2019) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b18-00937 · Cited by 37
Ceramide Kinase and the Ceramide-1-Phosphate/cPLA2α Interaction as a Therapeutic Target
Lamour, N. F., & Chalfant, C. E. (2008) · Current Drug Targets · doi:10.2174/138945008785132349 · Cited by 36
Blood–Brain Barrier Driven Pharmacoresistance in Amyotrophic Lateral Sclerosis and Challenges for Effective Drug Therapies
Mohamed, L. A., Markandaiah, S. S., Bonanno, S., Pasinelli, P., & Trotti, D. (2017) · The AAPS Journal · doi:10.1208/s12248-017-0120-6 · Cited by 35
Morphometric analysis of the cerebral expression of ATP-binding cassette transporter protein ABCB1 in chronic schizophrenia: Circumscribed deficits in the habenula
Bernstein, H., Hildebrandt, J., Dobrowolny, H., Steiner, J. H., Bogerts, B., & Pahnke, J. (2016) · Schizophrenia Research · doi:10.1016/j.schres.2016.02.036 · Cited by 34
Selective induction of P-glycoprotein at the CNS barriers during symptomatic stage of an ALS animal model
Chan, G. N. Y., Evans, R. A., Banks, D. B., Mesev, E. V., Miller, D. S., & Cannon, R. E. (2016) · Neuroscience Letters · doi:10.1016/j.neulet.2016.12.049 · Cited by 34
The ABC of glycosylation
Perego, P., Gatti, L., & Beretta, G. L. (2010) · Nature reviews. Cancer · doi:10.1038/nrc2789-c1 · Cited by 33
Newly Synthesized Oxygenated Xanthones as Potential P-Glycoprotein Activators: In Vitro, Ex Vivo, and In Silico Studies
Gil-Martins, E., Silva, V., Lemos, A., Palmeira, A., Puthongking, P., Sousa, E., Rocha‐Pereira, C., Ghanem, C. I., Carmo, H., Remião, F., et al. (2019) · Molecules · doi:10.3390/molecules24040707 · Cited by 33
Self-citation
Association between MDR1 gene polymorphisms and Parkinson's disease in Asian and Caucasian populations: a meta-analysis
Ahmed, S. S. S. J., Husain, R. S. A., Kumar, S., & Ramakrishnan, V. (2016) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2016.07.041 · Cited by 32
Lack of P-glycoprotein Results in Impairment of Removal of Beta-Amyloid and Increased Intraparenchymal Cerebral Amyloid Angiopathy after Active Immunization in a Transgenic Mouse Model of Alzheimer's Disease
Brückmann, S., Brenn, A., Grube, M., Niedrig, K., Holtfreter, S., Halbach, O. V. B. U., Groschup, M. H., Keller, M., & Vogelgesang, S. (2016) · Current Alzheimer Research · doi:10.2174/1567205013666161201201227 · Cited by 31
ABC Transporters in Neurological Disorders: An Important Gateway for Botanical Compounds Mediated Neuro-Therapeutics
Jha, N. K., Kar, R., & Niranjan, R. (2019) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026619666190412121811 · Cited by 30
Ceramide 1-Phosphate Increases P-Glycoprotein Transport Activity at the Blood-Brain Barrier via Prostaglandin E2 Signaling
Mesev, E. V., Miller, D. S., & Cannon, R. E. (2017) · Molecular Pharmacology · doi:10.1124/mol.116.107169 · Cited by 30
Glutamate-Mediated Down-Regulation of the Multidrug-Resistance Protein BCRP/ABCG2 in Porcine and Human Brain Capillaries
Salvamoser, J. D., Avemary, J., Luna‐Munguía, H., Pascher, B., Getzinger, T., Pieper, T., Kudernatsch, M., Kluger, G. J., & Potschka, H. (2015) · Molecular Pharmaceutics · doi:10.1021/mp500841w · Cited by 28
New anticonvulsant candidates prevent P-glycoprotein (P-gp) overexpression in a pharmacoresistant seizure model in mice
Enrique, A., Ianni, M. E. D., Goicoechea, S., Lazarowski, A., Valle-Dorado, M. G., Costa, J. J. L., Rocha, L., Girardi, E., & Talevi, A. (2019) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2019.106451 · Cited by 28
P‐glycoprotein (ABCB1) and Breast Cancer Resistance Protein (ABCG2) Localize in the Microvessels Forming the Blood‐Tumor Barrier in Ependymomas
Ginguené, C., Champier, J., Maallem, S., Strazielle, N., Jouvet, A., Fèvre‐Montange, M., & Ghersi‐Egea, J. (2010) · Brain Pathology · doi:10.1111/j.1750-3639.2010.00389.x · Cited by 28
The expression of P‐glycoprotein is increased in vessels with blood‐brain barrier impairment in a stroke‐prone hypertensive model
Ueno, M., Nakagawa, T., Huang, C. ‐., Ueki, M., Kusaka, T., Hosomi, N., Kanenishi, K., Onodera, M., Wu, B., & Sakamoto, H. (2008) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2008.00966.x · Cited by 27
Development of Novel Rifampicin-Derived P-Glycoprotein Activators/Inducers. Synthesis, In Silico Analysis and Application in the RBE4 Cell Model, Using Paraquat as Substrate
Vilas‐Boas, V., Silva, R., Palmeira, A., Sousa, E., Ferreira, L. M., Branco, P. S., Carvalho, F. D., Bastos, M. D. L., & Remião, F. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074425 · Cited by 27
Self-citation
ABCB1 Attenuates the Brain Penetration of the PARP Inhibitor AZD2461
de Gooijer, M. C., Buil, L. C. M., Çitirikkaya, C. H., Hermans, J., Beijnen, J. H., & van Tellingen, O. (2018) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.8b00742 · Cited by 27
Immunolocalization of ABC drug transporters in human placenta from normal and gestational diabetic pregnancies
Kozłowska-Rup, D., Czekaj, P., Plewka, D., & Sikora, J. (2014) · Ginekologia Polska · doi:10.17772/gp/1745 · Cited by 26
ATP-binding cassette transporters in primary central nervous system lymphoma: Decreased expression of MDR1 P-glycoprotein and breast cancer resistance protein in tumor capillary endothelial cells
Fujiwara (2010) · Oncology Reports · doi:10.3892/or.2010.1102 · Cited by 26
P-glycoprotein Inhibitor Tariquidar Potentiates Efficacy of Astragaloside IV in Experimental Autoimmune Encephalomyelitis Mice
Zhang, W., Liu, M., Liu, Y., Huang, F., Lan, Y., Li, H., Wu, H., Zhang, B., Shi, H., & Wu, X. (2019) · Molecules · doi:10.3390/molecules24030561 · Cited by 25
Repetitive/temporal hypoxia increased P-glycoprotein expression in cultured rat brain microvascular endothelial cells in vitro
Xiao-Dong, L., Yang, Z., & Yang, H. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2007.12.017 · Cited by 25
Intestinal absorption mechanisms of 2′-deoxy-2′-β-fluoro-4′-azidocytidine, a cytidine analog for AIDS treatment, and its interaction with P-glycoprotein, multidrug resistance-associated protein 2 and breast cancer resistance protein
Liu, Y., Liu, B., Zhang, Y., Peng, Y., Huang, C., Wang, N., Jiang, J., Wang, Q., & Chang, J. (2017) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2017.05.009 · Cited by 25
Pesticide-Induced Gene Mutations and Parkinson Disease Risk: A Meta-Analysis
Liu, X., Ma, T., Qu, B., Ji, Y., & Liu, Z. (2013) · Genetic Testing and Molecular Biomarkers · doi:10.1089/gtmb.2013.0313 · Cited by 24
Glutamate-Mediated Upregulation of the Multidrug Resistance Protein 2 in Porcine and Human Brain Capillaries
Luna‐Munguía, H., Salvamoser, J. D., Pascher, B., Pieper, T., Getzinger, T., Kudernatsch, M., Kluger, G. J., & Potschka, H. (2014) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.114.218180 · Cited by 24
Actin filament‐associated protein 1 (AFAP‐1) is a key mediator in inflammatory signaling‐induced rapid attenuation of intrinsic P‐gp function in human brain capillary endothelial cells
Hoshi, Y., Uchida, Y., Tachikawa, M., Ohtsuki, S., & Terasaki, T. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.13960 · Cited by 23
Validation of Thiosemicarbazone Compounds as P-Glycoprotein Inhibitors in Human Primary Brain–Blood Barrier and Glioblastoma Stem Cells
Salaroglio, I. C., Abate, C., Rolando, B., Battaglia, L., Gazzano, E., Colombino, E., Costamagna, C., Annovazzi, L., Mellai, M., Berardi, F., et al. (2019) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.9b00018 · Cited by 23
Lysophosphatidic acid and amitriptyline signal through LPA1R to reduce P-glycoprotein transport at the blood–brain barrier
Banks, D. B., Chan, G. N. Y., Evans, R. A., Miller, D. S., & Cannon, R. E. (2017) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x17705786 · Cited by 22
Chiral Thioxanthones as Modulators of P-glycoprotein: Synthesis and Enantioselectivity Studies
Lopes, A., Gil-Martins, E., Silva, R., Pinto, M. M. M., Remião, F., Sousa, E., & Fernandes, C. (2018) · Molecules · doi:10.3390/molecules23030626 · Cited by 22
Self-citation
Silymarin as a flavonoid-type P-glycoprotein inhibitor with impact on the pharmacokinetics of carbamazepine, oxcarbazepine and phenytoin in rats
Ferreira, A., Rodrigues, M., Meirinho, S., Fortuna, A. C., Falcão, A. C., & Alves, G. (2019) · Drug and Chemical Toxicology · doi:10.1080/01480545.2019.1601736 · Cited by 22
A new approach for Alzheimer's disease treatment through P-gp regulation via ibuprofen
Zhang, C., Qin, H., Zheng, R., Wang, Y., Yan, T., Huan, F., Han, Y., Zhu, W., & Zhang, L. (2018) · Pathology - Research and Practice · doi:10.1016/j.prp.2018.08.011 · Cited by 21
Distribution of domperidone into the rat brain is increased by brain ischaemia or treatment with the P-glycoprotein inhibitor verapamil
Dan, Y., 村上, 秀., Koyabu, N., Ohtani, H., & Sawada, Y. (2002) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357021778880 · Cited by 21
P-glycoprotein (ABCB1) activity decreases raltegravir disposition in primary CD4+P-gphighcells and correlates with HIV-1 viral load
Minuesa, G., Arimany-Nardí, C., Erkizia, I., Cedeño, S., Moltó, J., Clotet, B., Pastor‐Anglada, M., & Martínez‐Picado, J. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw215 · Cited by 21
The role of common variation in drug transporter genes in refractory epilepsy
Soranzo, N., Goldstein, D. B., & Sisodiya, S. M. (2005) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.6.8.1305 · Cited by 21
Glutathione depletion upregulates P-glycoprotein expression at the blood-brain barrier in rats
Wu, J., Hong, H., Ji, H., Wang, Y. Y., Wang, Y., Li, Y. Q., Li, W. G., Long, Y., & Xia, Y. Z. (2009) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.61.06.0016 · Cited by 20
Neurovascular Alterations in Alzheimer’s Disease: Transporter Expression Profiles and CNS Drug Access
McInerney, M. P., Short, J. L., & Nicolazzo, J. A. (2017) · The AAPS Journal · doi:10.1208/s12248-017-0077-5 · Cited by 20
Expression of ATP-binding cassette membrane transporters in a HIV-1 transgenic rat model
Robillard, K. R., Hoque, M. T., & Bendayan, R. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.01.092 · Cited by 20
The ATP-binding cassette transporters ABCB1 and ABCC1 are not regulated by hypoxia in immortalised human brain microvascular endothelial cells
Patak, P., Jin, F., Schäfer, S. T., Metzen, E., & Hermann, D. M. (2011) · Experimental & Translational Stroke Medicine · doi:10.1186/2040-7378-3-12 · Cited by 19
Associations between MDR1 C3435T polymorphism and drug-resistant epilepsy in the Polish population
Skalski, D., Wendorff, J., Romanowicz, H., Rysz, A., Marchel, A., Stasiołek, M., & Smolarz, B. (2016) · Acta Neurologica Belgica · doi:10.1007/s13760-016-0690-6 · Cited by 19
Role of P-Glycoprotein in Regulating Cilnidipine Distribution to Intact and Ischemic Brain
Yano, K., Takimoto, S., Motegi, T., Tomono, T., Hagiwara, M., Idota, Y., Morimoto, K., Takahara, A., & Ogihara, T. (2013) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.dmpk-13-rg-072 · Cited by 18
P-glycoprotein expression in brain capillary endothelial cells after focal ischaemia in the rat
Samoto, K., Ikezaki, K., Yokoyama, N., & Fukui, M. (1994) · Neurological Research · doi:10.1080/01616412.1994.11740231 · Cited by 18
Transporters Revealed
Lee, J., & Rosenbaum, D. M. (2017) · Cell · doi:10.1016/j.cell.2017.02.033 · Cited by 17
AnIn VivoMicrodialysis Study of FLZ Penetration through the Blood-Brain Barrier in Normal and 6-Hydroxydopamine Induced Parkinson’s Disease Model Rats
Hou, J., Liu, Q., Li, Y., Sun, H., & Zhang, J. (2014) · BioMed Research International · doi:10.1155/2014/850493 · Cited by 17
P-Glycoprotein Expression in Brain Capillary Endothelial Cells After Focal Ischemia in Rat
Samoto, K., Ikezaki, K., Yokoyama, N., & Fukui, M. (1994) · Springer eBooks · doi:10.1007/978-3-7091-9334-1_68 · Cited by 17
The potentially protective role of ATP-binding cassette transporters in preeclampsia via Nrf2
Yu, L., Wang, T., Que, R., Yang, J., Wang, Z. K., Jiang, X., & Wang, L. (2019) · Pregnancy Hypertension · doi:10.1016/j.preghy.2019.08.002 · Cited by 16
Quantitative determination and pharmacokinetic study of the novel anti-Parkinson's disease candidate drug FLZ in rat brain by high performance liquid chromatography–tandem mass spectrometry
Hou, J., Qu, F., Wu, C., Ren, Q., & Zhang, J. (2012) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2012.03.001 · Cited by 16
TAP and TAP-like — Brothers in arms?
Zhao, C., Tampé, R., & Abele, R. (2006) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/s00210-005-0028-z · Cited by 16
HIV-1 Tat Protein Enhances Expression and Function of Breast Cancer Resistance Protein
Zhou, Y., Zhang, K., Yin, X., Nie, Q., & Ma, Y. (2015) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2015.0117 · Cited by 15
ATP-Binding Cassette Transporters at the Blood-Brain Barrier in Ischaemic Stroke
Patak, P., & Hermann, D. M. (2011) · Current Pharmaceutical Design · doi:10.2174/138161211797440195 · Cited by 14
Regulation of P-glycoprotein by Bajijiasu in vitro and in vivo by activating the Nrf2-mediated signalling pathway
Yang, X., Guoyan, H., Lv, L., Liu, T., Qi, L., Huang, G., You, D., & Zhao, J. (2019) · Pharmaceutical Biology · doi:10.1080/13880209.2019.1582679 · Cited by 14
The Role of P-Glycoprotein in Psychiatric Disorders: A Reliable Guard of the Brain?
de Klerk, O. L., Bosker, F. J., Luurtsema, G., Nolte, I. M., Dierckx, R., den Boer, J. A., & Potschka, H. (2011) · Central Nervous System Agents in Medicinal Chemistry · doi:10.2174/187152411798047744 · Cited by 12
Role of ABC transporters in the pathology of Alzheimer’s disease
Zhao, Y., Hou, D., Feng, X., Lin, F., & Luo, J. (2016) · Reviews in the Neurosciences · doi:10.1515/revneuro-2016-0060 · Cited by 11
Common mental disorders through the eyes of German employees: attributed relevance of work-related causes and prevention measures assessed by a standardised survey
Burgess, S., Junne, F., Rothermund, E., Zipfel, S., Gündel, H., Rieger, M. A., & Michaelis, M. (2019) · International Archives of Occupational and Environmental Health · doi:10.1007/s00420-019-01414-7 · Cited by 11
Creutzfeldt-Jakob disease with Alzheimer pathology, presenting with status epilepticus following repeated partial seizures: a case report and literature review
Miyake, K., Hara, T., Oshima, E., Kawada, K., Ishizu, H., Yamauchi, Y., Satoh, K., Kitamoto, T., Takenoshita, S., Terada, S., et al. (2018) · BMC Neurology · doi:10.1186/s12883-018-1055-y · Cited by 11
The potential role of human multidrug resistance protein 1 (MDR1) and multidrug resistance-associated protein 2 (MRP2) in the transport of Huperzine Ain vitro
Fei, Z., Hu, M., Baum, L., Kwan, P., Hong, T., & Zhang, C. (2019) · Xenobiotica · doi:10.1080/00498254.2019.1623935 · Cited by 10
ABCB1 1199G > A Polymorphism Impacts Transport Ability of P-gp-Mediated Antipsychotics
Wang, R., Sun, X., Deng, Y.-S., & Qiu, X.-W. (2018) · DNA and Cell Biology · doi:10.1089/dna.2017.4096 · Cited by 9
ATP-binding cassette transporters limit the brain penetration of Wee1 inhibitors
de Gooijer, M. C., Buil, L. C. M., Beijnen, J. H., & van Tellingen, O. (2017) · Investigational New Drugs · doi:10.1007/s10637-017-0539-8 · Cited by 9
Acute Neurotoxicity Models of Prion Disease
Islam, A. M. T., Adlard, P. A., Finkelstein, D. I., Lewis, V., Biggi, S., Biasini, E., & Collins, S. J. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.7b00517 · Cited by 9
The effects of human immunodeficiency virus infection on the expression of the drug efflux proteins P-glycoprotein and breast cancer resistance protein in a human intestine model
Ellis, K., Marlin, J. W., Taylor, T. A. H., Fitting, S., Hauser, K. F., Rice, G. D., & McRae, M. (2014) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.12329 · Cited by 7
Abcb1a (P-glycoprotein) limits brain exposure of the anticancer drug candidate seliciclib in vivo in adult mice
Erdő, F., Nagy, I., Tóth, B., Bui, A., Molnar, E. M., Tímár, Z., Magnan, R., & Krajcsi, P. (2017) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2017.06.013 · Cited by 7
Sporadic Creutzfeldt–Jakob disease presenting as dizziness and cognitive decline
Xu, Y., Xu, J., Zhang, J., Cai, Z., Wei, H., Yu, M., & Li, Y. (2019) · Medicine · doi:10.1097/md.0000000000016002 · Cited by 5
ABCB1 1199G>A Polymorphism Affects the Intracellular Accumulation of Antidepressants in LLC-PK1 Recombinant Cell Lines
Gao, Y., & He, B. (2018) · DNA and Cell Biology · doi:10.1089/dna.2018.4391 · Cited by 5
Association ofABCG2polymorphisms with ischemic stroke in a Chinese population
Liu, T., Jiang, F., Liu, X., Zhang, H., Wang, L., Liu, W., & Wang, X. (2018) · Annals of Human Genetics · doi:10.1111/ahg.12258 · Cited by 3

Flagged first, then by citations

4 of the 379 references couldn’t be matched to a known paper.

Research works printed but not linked: 3

Goldenberg, 2012, Multiple sclerosis review, Pharmacy and Therapeutics, 37, 175
Liu, 2018, Effects of the antiretroviral drug 2′-deoxy-2′-beta-fluoro-4′-azidocytidine (FNC) on P-gp, MRP2 and BCRP expressions and functions, Pharmazie, 73, 503
Schulz, 2015, Depression, Continuum (Minneap Minn), 21, 756, 10.1212/01.CON.0000466664.35650.b4 · DOI

Sorted by citations

Brain penetrating peptides and peptide–drug conjugates to overcome the blood–brain barrier and target CNS diseases
Zhou, X., Smith, Q. R., & Liu, X. (2021) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1695 · Cited by 229
Blood–Brain Barrier Breakdown in Alzheimer’s Disease: Mechanisms and Targeted Strategies
Alkhalifa, A. E., Al-Ghraiybah, N. F., Odum, J., Shunnarah, J. G., Austin, N., & Kaddoumi, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242216288 · Cited by 212
Lipid nanoparticles strategies to modify pharmacokinetics of central nervous system targeting drugs: Crossing or circumventing the blood–brain barrier (BBB) to manage neurological disorders
Correia, A. D. A., Monteiro, A. R., Silva, R., Moreira, J. N., Lobo, J. M. S., & Silva, A. C. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114485 · Cited by 219
Self-citation
Hypoxia, Oxidative Stress, and Inflammation: Three Faces of Neurodegenerative Diseases
Merelli, A., Repetto, M. G., Lazarowski, A., & Auzmendi, J. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-201074 · Cited by 188
Oxidative stress, the blood–brain barrier and neurodegenerative diseases: The critical beneficial role of dietary antioxidants
Feng, J., Zheng, Y., Guo, M., Arés, I., Martínez, M., López-Torres, B., Martínez‐Larrañaga, M., Wang, X., Anadón, A., & Martínez, M. (2023) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2023.07.010 · Cited by 187

See all 152

Authors: Gil-Martins, E., Barbosa, D. J., Silva, V., Remião, F., & Silva, R.
Affiliations: Universidade do Porto (PT)
Corresponding author: Remião, Fernando
Silva, Renata
ORCID: Gil-Martins, Eva
Barbosa, Daniel José
Silva, Vera
Remião, Fernando
Silva, Renata
Venue: Pharmacology & Therapeutics
Publisher: Elsevier BV
Published: 2020-09
Volume: 213
Pages: 107554
ISSN: 0163-7258 (ISSN-L)
DOI: 10.1016/j.pharmthera.2020.107554
OpenAlex: W3017050326
Cited by: 152
References: 379
Citations by year: 2026: 16 · 2025: 23 · 2024: 18 · 2023: 33 · 2022: 33 · 2021: 22 · 2020: 7
FWCI: 2.55
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
Locations: Pharmacology & Therapeutics (publishedVersion)
PubMed (publishedVersion)
Funders: Fundação para a Ciência e a Tecnologia
Topics: Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
Keywords: ABC transporters, blood-brain barrier, P-glycoprotein, ABCG2, multidrug resistance protein, neurological disorders, epilepsy, multiple sclerosis, Alzheimer's disease, amyotrophic lateral sclerosis, drug resistance, signaling pathways, transporter regulation, drug bioavailability
MeSH terms: Animals, Blood-Brain Barrier, Brain, Central Nervous System Agents, Drug Resistance, Humans, Nervous System Diseases, ATP-Binding Cassette Transporters

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Dysfunction of ABC transporters at the blood-brain barrier: Role in neurological disorders

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks